TeVido’s therapy-as-a-service (TAAS) stands to address significant unmet needs in reconstructive and cosmetic surgery with autologous cell therapy for patients with vitiligo and nipple areola reconstruction for breast cancer survivors. Currently, vitiligo patients are unable to easily access the most effective treatment options and breast cancer survivors who choose to have reconstructive survey have limited options when it comes to the aesthetic outcome of their procedure. Our techniques in biofabrication and 3-D bioprinting support deposition of cells and biomaterials in precise locations, layer by layer, which results in a highly customizable product, improving outcomes and changing lives.
TeVido is a combination of two spanish words, tejido (tissue) and vida (life).
This is our mission
At TeVido BioDevices, we use a patient's own tissue to enhance the quality of their life.
For those interested in a technical overview, please Contact Us.
Laura Bosworth, CEO and co-founder, is a dynamic former Fortune 50 executive with nearly 30 years of cross-functional industry experience. She has over 20 years in product, process and service development at both the engineering and marketing level.
With a B.S. in Engineering, she started her career in manufacturing process development and quickly moved into management. She honed her product development skills leading custom software projects that included creation and execution of multiple technical sales support functions, enabling over $500M in sales. She was frequently recognized for her contributions to sales and her ability to understand customer pain-points led her to leadership roles in product marketing. She launched several new business start-ups, such as professional services, within a larger corporation and has expertise in customer support services. Using her cross-functional and international experience, she developed corporate wide quality strategies that reduced operating costs by ~$120M and improved customer satisfaction by 40-50%.
Ms. Bosworth is active, in Board positions as well as providing direct service, for numerous non-profits, primarily supporting women’s needs in the STEM field, entrepreneurship as well as domestic violence. She was a Spanish interpreter at a Volunteer Healthcare Clinic that serves low-income individuals.
Dr. John Harris, is an Assistant Professor in the Dermatology Division, Department of Medicine at the University of Massachusetts Medical School (UMMS) in Worcester, MA. Dr. Harris directs the Vitiligo Clinic and Research Center at UMMS, which incorporates a specialty clinic for the diagnosis and treatment of patients with vitiligo, as well as a vitiligo research laboratory. He uses basic, translational, and clinical research approaches to better understand autoimmunity in vitiligo, with a particular focus on developing more effective treatments.
Michael Matula holds a PhD in BioChemistry and JD from The University of Texas. He has been a practicing attorney and businessman with experience in real estate development, oil & gas exploration and services, investments, and law. From 2004 to 2009 he was President & CEO of an oilfield services company in Carthage, Texas. He is an active angel investor and a former member of Central Texas Angel Network. He has invested in over 40 early stage companies across a broad range of industries. He has led several life sciences deals and currently sits on the board of Paratus Diagnostics.
Elisa Maldonado-Holmertz has over 20 years experience in multinational pharma, life sciences and medical device industries. She has worked locally in both emerging and established markets (USA, Belgium, Sweden, P.R. China) spanning an array of indications including wound healing. Most relevant to TeVido, she has been integral to several start-ups. In addition to her industry background, she has graduate work in Business Management and Health Economics. Her experience in clinical research, reimbursement and market access, marketing and sales, and RA/QA are of tremendous value to TeVido. Ms. Maldonado-Holmertz has recently left her position as VP Business Development at Emergo Group to pursue consulting.
Francisco Agullo, M.D., is certified by the American Board of Plastic Surgery and the American Board of Surgery. He has joined El Paso Cosmetic Surgery as a plastic surgeon serving the cosmetic needs of West Texas, New Mexico, and Northern Mexico.
Dr. Frank Agullo graduated from the world-famous Mayo Clinic in Rochester, Minnesota, and he stays current in all of the latest aesthetic procedures and technologies. Dr. Agullo also holds the position of clinical assistant professor at Texas Tech University.